Evaluation of the Center for Tobacco Products Public Education Campaigns, Communication Programs and Channels
Closed Solicitation Posted
- Solicitation number
- FDA-SOL-1234457
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541910 Marketing Research and Public Opinion Polling
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration's Center for Tobacco Products seeks to establish an indefinite-delivery, indefinite-quantity contract to conduct evaluations of its public education campaigns, communication programs, and channels. The contractor shall perform process and outcome evaluations to assess implementation fidelity and changes in target audience knowledge, attitudes, beliefs, and behaviors from exposure to campaign messages. Evaluations must account for influences on tobacco use and the evolving product landscape using quantitative and qualitative methodologies. Proposals are due March 8, 2021 and shall detail experience evaluating large public health behavior change campaigns and the capability to support nationwide research.
There is no set-aside designation. The solicitation involves evaluation services under NAICS 541611 and PSC R425. The ceiling value for the five-year IDIQ contract is $60 million. Evaluations shall assess campaigns targeting youth and adult audiences nationally. The period of performance is through 2026 with all work to be conducted in Silver Spring, Maryland.
Notice text
3 versions
Update #3 · Latest ·
Updated 03/01/2021. An amendment to RFP Number: FDA-SOL-1234457, “Evaluation of the Center for Tobacco Products Public Education Campaigns, Communication Programs and Channels” has been posted. Please see the attachments section to view the amendment to the solicitation and added attachments J and K. Please note that the FDA is requiring offerors who have submitted proposals, to resubmit their proposals prior to the closing date of this solicitation. Please note this is a mandatory requirement if you wish to be considered under this solicitation. Proposals must be submitted by 12:00PM EST on March 8th, 2021 in order to be considered.
Updated 01/08/2021. Please see the additional revised attachment which amends Attachment G_RFP Question Submittal Form.
Tobacco smoking remains the leading cause of preventable death and disease in the United States, killing more than 480,000 Americans each year. Additionally, for every person who dies because of smoking, at least 30 people live with a serious smoking-related illness. The Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) was established by the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act, TCA) and tasked with developing and implementing effective regulatory strategies for reducing the enormous public health burden of tobacco products. Such strategies include public education activities to inform a variety of audiences about tobacco products and their regulation. Given that nine out of ten adult people who smoke started smoking before the age of 18, public education activities place a special emphasis on preventing and reducing tobacco use among young people in the United States. Using the best available science, CTP is executing a comprehensive mix of health communication and education activities designed to discourage tobacco use. Health communication activities, such as public education campaigns are known to shape tobacco-related knowledge, opinions, attitudes, and behaviors among individuals and within communities (National Cancer Institute, 2008).
CTP seeks to conduct timely evaluations of its health communication and education activities on reducing tobacco-related death and disease to measure its impact and effectiveness. These activities will include pre-testing of evaluation methodologies to assess effectiveness of new evaluation approaches, process evaluations to assess whether activities were conducted as planned, and outcome evaluations to assess how well program activities achieved the intended goals and objectives. Health communication outcome evaluation measures will include gauging target audience exposure to, awareness of, and receptivity to messages in relation to resultant changes in tobacco-related knowledge, attitudes, beliefs, and behaviors.
Evaluation of CTP's education activities, particularly campaigns, is complicated by the multiple factors that influence tobacco initiation, use, and cessation behaviors. These include, but are not limited to, tobacco policies, regulatory enforcement, other tobacco prevention education programs, community tobacco prevention efforts, media exposure, and socioeconomic and demographic factors. CTP evaluation activities are further complicated by the evolving tobacco product landscape, and the emergence of new products has implications for campaign message strategies and target audience. Also, measuring exposure to specific campaigns is increasingly complicated, particularly given the increased reliance on digital media for reaching campaign target audiences. Self-reported exposure to media can be unreliable, and simultaneous exposure to other media messages (including both tobacco industry messages and other tobacco prevention messaging) is unavoidable. CTP therefore requires rigorous scientific evaluations of its tobacco-related public education activities and programs that account for these complex factors. Successful evaluation should include quantitative and qualitative methodologies that measure progress toward successful outcomes, identify the need for mid-course adjustments to improve effectiveness, and assess long-term public health impact.
Update #2 ·
Updated 01/08/2021. Please see the additional revised attachment which amends Attachment G_RFP Question Submittal Form.
Tobacco smoking remains the leading cause of preventable death and disease in the United States, killing more than 480,000 Americans each year. Additionally, for every person who dies because of smoking, at least 30 people live with a serious smoking-related illness. The Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) was established by the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act, TCA) and tasked with developing and implementing effective regulatory strategies for reducing the enormous public health burden of tobacco products. Such strategies include public education activities to inform a variety of audiences about tobacco products and their regulation. Given that nine out of ten adult people who smoke started smoking before the age of 18, public education activities place a special emphasis on preventing and reducing tobacco use among young people in the United States. Using the best available science, CTP is executing a comprehensive mix of health communication and education activities designed to discourage tobacco use. Health communication activities, such as public education campaigns are known to shape tobacco-related knowledge, opinions, attitudes, and behaviors among individuals and within communities (National Cancer Institute, 2008).
CTP seeks to conduct timely evaluations of its health communication and education activities on reducing tobacco-related death and disease to measure its impact and effectiveness. These activities will include pre-testing of evaluation methodologies to assess effectiveness of new evaluation approaches, process evaluations to assess whether activities were conducted as planned, and outcome evaluations to assess how well program activities achieved the intended goals and objectives. Health communication outcome evaluation measures will include gauging target audience exposure to, awareness of, and receptivity to messages in relation to resultant changes in tobacco-related knowledge, attitudes, beliefs, and behaviors.
Evaluation of CTP's education activities, particularly campaigns, is complicated by the multiple factors that influence tobacco initiation, use, and cessation behaviors. These include, but are not limited to, tobacco policies, regulatory enforcement, other tobacco prevention education programs, community tobacco prevention efforts, media exposure, and socioeconomic and demographic factors. CTP evaluation activities are further complicated by the evolving tobacco product landscape, and the emergence of new products has implications for campaign message strategies and target audience. Also, measuring exposure to specific campaigns is increasingly complicated, particularly given the increased reliance on digital media for reaching campaign target audiences. Self-reported exposure to media can be unreliable, and simultaneous exposure to other media messages (including both tobacco industry messages and other tobacco prevention messaging) is unavoidable. CTP therefore requires rigorous scientific evaluations of its tobacco-related public education activities and programs that account for these complex factors. Successful evaluation should include quantitative and qualitative methodologies that measure progress toward successful outcomes, identify the need for mid-course adjustments to improve effectiveness, and assess long-term public health impact.
Update #1 ·
Tobacco smoking remains the leading cause of preventable death and disease in the United States, killing more than 480,000 Americans each year. Additionally, for every person who dies because of smoking, at least 30 people live with a serious smoking-related illness. The Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) was established by the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act, TCA) and tasked with developing and implementing effective regulatory strategies for reducing the enormous public health burden of tobacco products. Such strategies include public education activities to inform a variety of audiences about tobacco products and their regulation. Given that nine out of ten adult people who smoke started smoking before the age of 18, public education activities place a special emphasis on preventing and reducing tobacco use among young people in the United States. Using the best available science, CTP is executing a comprehensive mix of health communication and education activities designed to discourage tobacco use. Health communication activities, such as public education campaigns are known to shape tobacco-related knowledge, opinions, attitudes, and behaviors among individuals and within communities (National Cancer Institute, 2008).
CTP seeks to conduct timely evaluations of its health communication and education activities on reducing tobacco-related death and disease to measure its impact and effectiveness. These activities will include pre-testing of evaluation methodologies to assess effectiveness of new evaluation approaches, process evaluations to assess whether activities were conducted as planned, and outcome evaluations to assess how well program activities achieved the intended goals and objectives. Health communication outcome evaluation measures will include gauging target audience exposure to, awareness of, and receptivity to messages in relation to resultant changes in tobacco-related knowledge, attitudes, beliefs, and behaviors.
Evaluation of CTP's education activities, particularly campaigns, is complicated by the multiple factors that influence tobacco initiation, use, and cessation behaviors. These include, but are not limited to, tobacco policies, regulatory enforcement, other tobacco prevention education programs, community tobacco prevention efforts, media exposure, and socioeconomic and demographic factors. CTP evaluation activities are further complicated by the evolving tobacco product landscape, and the emergence of new products has implications for campaign message strategies and target audience. Also, measuring exposure to specific campaigns is increasingly complicated, particularly given the increased reliance on digital media for reaching campaign target audiences. Self-reported exposure to media can be unreliable, and simultaneous exposure to other media messages (including both tobacco industry messages and other tobacco prevention messaging) is unavoidable. CTP therefore requires rigorous scientific evaluations of its tobacco-related public education activities and programs that account for these complex factors. Successful evaluation should include quantitative and qualitative methodologies that measure progress toward successful outcomes, identify the need for mid-course adjustments to improve effectiveness, and assess long-term public health impact.
Files
| File | Type | Posted |
|---|---|---|
| Amend2_RFP_FDA-SOL-1234457.pdf | ||
| Amend2_Attachment J_SAMPLE Task Order SOW.docx | DOCX document | |
| Amend2_Attachment K_Fact Sheet for FDA-SOL-1234457.docx | DOCX document | |
| Amend1_Attachment G_Question Submittal Form.xlsx | XLSX spreadsheet | |
| Attachment I_PPQ.docx | DOCX document | |
| Attachment A_Campaign Evaluation Materials.pdf | ||
| Attachment H_Relevant Experience Form.docx | DOCX document | |
| Attachment G_Question Submittal Form.xlsx | XLSX spreadsheet | |
| Attachment D_IDIQ Pricing Worksheet.xlsx | XLSX spreadsheet | |
| Attachment F_Labor Category Descriptions.docx | DOCX document | |
| Attachment E_Standard Form LLL Disclosure of Lobbying Activities.pdf | ||
| RFP_FDA-SOL-1234457.docx | DOCX document | |
| Attachment C_ Wage Determinations.pdf | ||
| Attachment B_FAR Deviation 18-01 (Whistleblower Protection-Commercial).pdf |
Show all 14
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| FDA CTP Health Communication Research & Evaluation Program | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity